These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 236740)

  • 1. [Beta-adrenergic blocking agents of the flavone group. [(author's transl)]].
    Da Re P; Roveri P; Ferdenzi A; Murmann W
    Arch Pharm (Weinheim); 1975 Feb; 308(2):114-8. PubMed ID: 236740
    [No Abstract]   [Full Text] [Related]  

  • 2. [Synthesis and beta-adrenergic blocking activity of 1-amino-3-(1,3-dioxalan-2-ylphenyloxy) propan-2-ols and 1-amino-3-(183-dioxan-2-ylphenyloxy)-propan-2-ols (author's transl)].
    Janiak PS; Moser U; Mutschler E
    Arch Pharm (Weinheim); 1978 Feb; 311(2):131-5. PubMed ID: 25640
    [No Abstract]   [Full Text] [Related]  

  • 3. Synthesis and pharmacological evaluation of novel potential ultrashort-acting beta-blockers.
    Mokrý P; Zemanová M; Csöllei J; Racanská E; Tumová I
    Pharmazie; 2003 Jan; 58(1):18-21. PubMed ID: 12622246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Derivatives related to betaxolol with alpha- and beta-adrenergic activities.
    Leclerc G; Decker N; Schwartz J
    Arzneimittelforschung; 1985; 35(9):1357-67. PubMed ID: 2867769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and irreversible beta-adrenergic blockade with a bromoacetamido derivative of betaxolol.
    Amlaiky N; Leclerc G
    J Pharm Sci; 1985 Oct; 74(10):1117-9. PubMed ID: 2867200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultra-short-acting beta-adrenergic receptor blocking agents. 1. (Aryloxy)propanolamines containing esters in the nitrogen substituent.
    Erhardt PW; Woo CM; Gorczynski RJ; Anderson WG
    J Med Chem; 1982 Dec; 25(12):1402-7. PubMed ID: 6130153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [On the synthesis of compounds with beta-adrenergic activity (author's transl)].
    Lehmann D; Eckardt R; Faust G; Fiedler W
    Pharmazie; 1980; 34(5-6):278-84. PubMed ID: 6106206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardioselective beta-adrenergic blocking agents. 1. 1-((3,4-Dimethoxyphenethyl)amino)-3-aryloxy-2-propanols.
    Hoefle ML; Hastings SG; Meyer RF; Corey RM; Holmes A; Stratton CD
    J Med Chem; 1975 Feb; 18(2):148-52. PubMed ID: 235644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultra-short-acting beta-adrenergic receptor blocking agents. 2. (Aryloxy)propanolamines containing esters on the aryl function.
    Erhardt PW; Woo CM; Anderson WG; Gorczynski RJ
    J Med Chem; 1982 Dec; 25(12):1408-12. PubMed ID: 6130154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-adrenoceptor studies. 1. In vitro beta-adrenergic blocking, antiarrhythmic, and local anesthetic activities of a new series of aromatic bis(2-hydroxy-3-isopropylaminopropyl) ethers.
    Zaagsma J; Nauta WT
    J Med Chem; 1974 May; 17(5):507-13. PubMed ID: 4151492
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis and beta-adrenergic activity of new completely aliphatic 3-(methyleneaminoxy)propanolamine derivatives.
    Balsamo A; Gentili D; Lapucci A; Macchia M; Martinelli A; Orlandini E; Ferni G; Pinza M
    Farmaco; 1994 Dec; 49(12):759-66. PubMed ID: 7893332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unambiguous synthesis of 1-(7-indenyloxy)-3-isopropylamino-2-propanol hydrochloride and its 4-indenyloxy isomer, potent beta-adrenergic blocking agents.
    Murase K; Tamazawa K; Mase T; Tachikawa S; Shiobara Y
    Chem Pharm Bull (Tokyo); 1976 Mar; 24(3):552-4. PubMed ID: 14788
    [No Abstract]   [Full Text] [Related]  

  • 13. beta-Adrenergic blocking agents. alpha- and gamma-methyl(aryloxy)propanolamines.
    Lemke TL; Cramer MB; Adamski SW; Pedone CA; Brooker G
    J Med Chem; 1981 Oct; 24(10):1211-4. PubMed ID: 6120233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Derivatives of 3,4-dihydrocarbostyril as beta-adrenergic blocking agents.
    Nakagawa K; Murakami N; Yoshizaki S; Tominaga M; Mori H
    J Med Chem; 1974 May; 17(5):529-33. PubMed ID: 4151493
    [No Abstract]   [Full Text] [Related]  

  • 15. Syntheses of the optical isomers of befunolol.HCl and their beta-adrenergic blocking activities.
    Nakano J; Mimura M; Hayashida M; Fujii M; Kimura K; Nakanishi T
    Chem Pharm Bull (Tokyo); 1988 Apr; 36(4):1399-403. PubMed ID: 2901296
    [No Abstract]   [Full Text] [Related]  

  • 16. Beta-Adrenergic blocking agents. Nitrogen heteroaryl-substituted 2-propanolamines and ethanolamines.
    Meyer RF; Stratton CD; Hastings SG; Corey RM
    J Med Chem; 1973 Oct; 16(10):113-6. PubMed ID: 4147942
    [No Abstract]   [Full Text] [Related]  

  • 17. Nondepressant beta-adrenergic blocking agents. 1. Substituted 3-amino-1-(5,6,7,8-tetrahydro-1-naphthoxy)-2-propanols.
    Condon ME; Cimarusti CM; Fox R; Narayanan VL; Reid J; Sundeen JE; Hauck FP
    J Med Chem; 1978 Sep; 21(9):913-22. PubMed ID: 31485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ether derivatives of 3-amino-1,2-propanediol, II: synthesis and pharmacological investigation of n-substituted derivatives of 1-cycloalkyloxy-3-amino-2-propanols (author's transl)].
    Dantschev D; Georgiev A; Tschalina E; Dobreva-Usunova D; Staneva D
    Arch Pharm (Weinheim); 1979 Oct; 312(10):857-63. PubMed ID: 44460
    [No Abstract]   [Full Text] [Related]  

  • 19. -Adrenergic blocking agents of the chromone and xanthone groups.
    Da Re P; Valenti P; Borraccini A; Primofiore GP
    J Med Chem; 1972 Feb; 15(2):198-9. PubMed ID: 4400150
    [No Abstract]   [Full Text] [Related]  

  • 20. A new series of tricyclic (aryloximino)propanolamines displaying very high selective beta 2-blocking properties.
    Jamart-Gregoire B; Caubere P; Blanc M; Gnassounou JP; Advenier C
    J Med Chem; 1989 Feb; 32(2):315-20. PubMed ID: 2563296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.